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Abstract
Streptococcus pneumoniae requires manganese for colonization of the human host, but the underlying molecular basis for
this requirement has not been elucidated. Recently, it was shown that zinc could compromise manganese uptake and that
zinc levels increased during infection by S. pneumoniae in all the niches that it colonized. Here we show, by quantitative
means, that extracellular zinc acts in a dose dependent manner to competitively inhibit manganese uptake by S.
pneumoniae, with an EC50 of 30.2 mM for zinc in cation-defined media. By exploiting the ability to directly manipulate S.
pneumoniae accumulation of manganese, we analyzed the connection between manganese and superoxide dismutase
(SodA), a primary source of protection for S. pneumoniae against oxidative stress. We show that manganese starvation led to
a decrease in sodA transcription indicating that expression of sodA was regulated through an unknown manganese
responsive pathway. Intriguingly, examination of recombinant SodA revealed that the enzyme was potentially a cambialistic
superoxide dismutase with an iron/manganese cofactor. SodA was also shown to provide the majority of protection against
oxidative stress as a S. pneumoniae DsodA mutant strain was found to be hypersensitive to oxidative stress, despite having
wild-type manganese levels, indicating that the metal ion alone was not sufficiently protective. Collectively, these results
provide a quantitative assessment of the competitive effect of zinc upon manganese uptake and provide a molecular basis
for how extracellular zinc exerts a ‘toxic’ effect on bacterial pathogens, such as S. pneumoniae.
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Introduction
Metal ions are essential for all known forms of life. In a
biological context, nearly one-third of all proteins require
interaction with a metal cofactor to facilitate their activity [1].
The d-block ion manganese, which exists as the divalent cation
Mn(II), is an essential trace element for almost all organisms and
serves in a wide range of enzymes involved in phosphorylation,
hydrolysis, carbon metabolism, decarboxylation, and oxidative
stress response [2]. Manganese also has a particularly prominent
role in protection against oxidative stress and is often a cofactor in
superoxide dismutase (SOD), where it catalyzes the one-electron
dismutation of superoxide to oxygen and hydrogen peroxide. The
crucial role of Mn(II) in cellular function has been highlighted by
its importance in the virulence of a number of bacteria, including
Bacillus anthracis, Staphylococcus aureus, Streptococcus (S.) pneumoniae, and
S. pyogenes [3–6]. S. pneumoniae (also known as the pneumococcus) is
one of the world’s foremost bacterial pathogens [7]. Although this
Gram-positive bacterium is typically carried asymptomatically in
the human nasopharynx in a large proportion of the population, it
is capable of spreading to the lungs and other tissues where it
causes a range of serious diseases including pneumonia, menin-
gitis, otitis media, and bacteraemia [7,8]_ENREF_2. The greatest
burden of pneumococcal disease occurs in developing countries.
Pneumonia, of which S. pneumoniae is the most common causal
agent, accounts for more than 1 million deaths per year, primarily
in children under 5 years of age from developing countries [9–11].
In developed countries, despite the availability of vaccination and
antimicrobial therapies, pneumococcal morbidity and mortality
remains substantial [8,12–14]. Deaths from pneumococcal disease
predominantly occur in individuals over 60 years of age, with
fatality rates of up to 20% for pneumonia and up to 60% for
bacteraemia [7]. Essential to the capacity of the pneumococcus to
mediate virulence is its ability to adapt and colonize different host
niches.
S. pneumoniae is an aerotolerant anaerobe that, although it lacks
catalase [15], is capable of detoxifying reactive oxygen species
(ROS) and peroxide by use of SOD and a thiol-peroxidase (PsaD).
The concerted actions of these enzymes enable the pneumococcus
to not only tolerate molecular oxygen, but to safely consume it via
reduction by cytoplasmic NADH oxidase (Nox) and pyruvate
oxidase (SpxB) [16–18], thereby increasing the yield of ATP per
mole of glucose. Protection against oxidative stress is intimately
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linked to cellular abundance of two transition row metals, iron and
manganese. By contrast with many other pathogens, the
pneumococcus has a relatively low requirement for iron. This is
presumably due to the lack of a complete respiratory chain and the
presence of only a few iron-sulfur containing proteins [19–21]. As
a consequence, the lower abundance of iron in the pneumococcus
reduces the possibility that hydroxyl radicals (.OH2) could arise
from the Fenton reaction of ferrous ions [Fe(II)] and hydrogen
peroxide (H2O2).
Manganese is specifically acquired by S. pneumoniae via the cell-
surface lipoprotein PsaA, and this recruitment is essential for
pneumococcal colonization and virulence in the human host
[4,22,23]. PsaA belongs to the Cluster A-I subgroup of solute-
binding proteins (SBPs) and interacts with an ATP-binding
cassette (ABC) transporter, PsaBC, to deliver the recruited ion
into the cell. Metal ion ABC permeases, which employ these types
of SBPs, do not have discrete binding sites for the ion and, as such,
all cargo specificity derives from the SBP [24,25]. Recently, work
from our group identified that despite the physiological role of
PsaA in Mn(II) acquisition, the protein was capable of binding
either its cognate ligand, Mn(II), or Zn(II) [22,26,27]. These
observations led to the identification of the relationship between
extracellular Zn(II) and Mn(II) starvation in S. pneumoniae, and a
concomitant increase in sensitivity to oxidative stress [26].
Although Mn(II) has many roles in cellular function [1,28–30], it
has a prominent contribution to oxidative stress management in
many organisms [2]. Manganese serves in this capacity primarily
as an essential cofactor of SOD [2,31], but also by potentially
substituting for ferrous iron in non-redox metabolic enzymes [32],
and by providing direct protection against oxidative stress in
organisms, such as Neisseria gonorrhoeae and Lactobacillus plantarum,
that do not produce a Mn(II)-SOD [33,34]. As a consequence,
although our earlier observations were consistent with both the
prior characterization of the pneumococcal SOD (SodA), which
suggested that it functioned as a Mn(II)-cofactor containing SOD
[35], and findings from related streptococcal species [36,37], these
data could not provide an unequivocal molecular explanation for
how Mn(II) availability influenced oxidative stress management.
Further confounding the issue, are recent studies of SODs
from several streptococcal species that have shown these enzymes
to be cambialistic proteins that utilize mixed iron/manganese
cofactors [36,38]. Thus, SodA from S. pneumoniae may not have
an explicit requirement for Mn(II), suggesting that the metal
ion could also potentially contribute to oxidative stress manage-
ment via other mechanisms. Hence, the role of Mn(II) in
protection against oxidative stress in S. pneumoniae requires further
elucidation.
In this study we further investigated the molecular basis for the
requirement of Mn(II) to identify the mechanisms by which
extracellular Zn(II) could exert a toxic effect on the pneumococ-
cus. By use of in vitro and in vivo analyses of S. pneumoniae our
findings reveal that Zn(II) induced Mn(II) starvation in S.
pneumoniae in a competitive manner. This resulted in an increase
in sensitivity to oxidative stress that occurred concomitantly with a
decrease in sodA transcription. Although the majority of physio-
logical protection from oxidative stress in the pneumococcus arose
from SodA, the Mn(II) ion was also shown to provide a low level of
protection. Collectively, these findings provide further insight into
the molecular basis of Zn(II) toxicity to S. pneumoniae, whilst also
being broadly applicable to other bacteria that employ related
pathways for Mn(II) acquisition.
Results
Extracellular zinc competes for manganese uptake by
S. pneumoniae
Results from our group and others have previously shown that
Mn(II) homeostasis in S. pneumoniae can be influenced by Zn(II)
concentrations and, when in large excess relative to Mn(II), result
in a reduction in cell-associated Mn(II) [26,39,40]. However, in
our prior studies the extent to which Zn(II) quantitatively
perturbed Mn(II) acquisition was restricted to two concentrations
[10 mM Zn(II):1 mM Mn(II) and 100 mM Zn(II):1 mM Mn(II)]
[26]. In this study we sought to further analyze the effect of Zn(II)
on S. pneumoniae D39 cell-associated Mn(II) when grown in a range
of increasing Zn(II):Mn(II) ratios in CDM (Fig. 1A). Consistent
with our previous observations, we observed that as the ratio of
Zn(II) increased, relative to 1 mM Mn(II), S. pneumoniae showed a
stepwise reduction in its growth rate. Inductively coupled plasma
mass spectrometry (ICP-MS) analysis of cells grown in CDM
supplemented with 1 mM Mn(II), had mean Mn(II) and Zn(II)
accumulation values of 8063 mg Mn(II).g cells21 (n=6) and
74610 mg Zn(II).g cells21 (n=6), respectively (Fig. 1B,C).
Consistent with our prior observations [26], the 10 mM
Zn(II):1 mM Mn(II) show no significant change in either the
growth rate or metal accumulation. Here we show, for the first
time, that growth in the presence of 30 mM Zn(II):1 mM Mn(II)
resulted in a minor, but significant, decrease in the growth rate
(Fig. 1A) and resulted in a 2-fold reduction in Mn(II) accumulation
(P , 0.0001) (Fig. 1B). Despite this, Zn(II) accumulation in S.
pneumoniae was not observed to significantly increase (P=0.73) (Fig.
1C). The 100 mM Zn(II):1 mM Mn(II) ratio induced a significant
perturbation in the growth rate S. pneumoniae (Fig. 1A) and,
consistent with our prior studies [26,40], metal accumulation was
also significantly affected, with Mn(II) accumulation reduced by
5.9-fold (P , 0.0001) (Fig. 1B), whilst Zn(II) accumulation showed
a minor increase of 1.4-fold (P=0.0091) (Fig. 1C). At ratios of
300 mM Zn(II):1 mM Mn(II) (Fig. 1A) or greater (data not shown)
growth of S. pneumoniae was completely inhibited and thus
precluded quantitative assessment of metal accumulation.
Previously we have observed that the phenotypic effect of Zn(II)
on pneumococcal growth could essentially be ablated by
supplementation with an equimolar concentration of Mn(II)
[26]. In this study we observed a similar trend, with the sole
exception being the 300 mM Zn(II):300 mM Mn(II) growth
condition (Fig. 1D). Here, we observed that although supplemen-
tation with 300 mMMn(II) could restore pneumococcal growth, at
what was an otherwise inhibitory concentration [300 mM
Zn(II):1 mM Mn(II); Fig. 1A], the growth rate still showed a
significant delay and overall reduction by comparison to the
unchallenged wild-type growth rate. This indicated that cellular
processes other than Mn(II) uptake were being detrimentally
affected during growth in the presence of very high levels of
extracellular Zn(II). We then sought to ascertain whether
supplementation with equimolar Mn(II), in the presence of Zn(II),
had restored Mn(II) levels as the phenotypic growth experiments
suggested. We show here, for the first time, that cell-associated
Mn(II) concentrations were indeed restored to unchallenged levels
when Mn(II) was supplemented at equimolar ratios to Zn(II) (Fig.
1E). Further, the concentrations of Zn(II) accumulated under these
conditions were essentially the same as the non-challenged
concentrations (Fig. 1F). The only exception was the 300 mM
Zn(II):300 mM Mn(II) growth condition that showed a ,2.5-fold
(P , 0.0001) increase in Zn(II) (Fig. 1F).
Analysis of the quantitative metal accumulation data for Mn(II)
collected in this study revealed that Zn(II) had an EC50 for Mn(II)
Zn(II) Competes for Mn(II) Uptake in S. pneumoniae
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accumulation at a ratio of 30.2 mM Zn(II):1 mM Mn(II) in CDM
(Fig. 2A). Therefore, the effect of extracellular Zn(II) on Mn(II)
accumulation was consistent with competitive phenomena, which
previously could only be inferred [26]. To assess whether
extracellular Zn(II) affected the accumulation of other metal ions
we further investigated the impact of competitive Zn(II) concen-
trations. As can be seen in Figures 2B-E, the effect of extracellular
Zn(II) on metal accumulation was primarily restricted to Mn(II)
accumulation, with no significant reduction in the accumulation of
other transition row metals observed at any of the competitive
ratios examined. However, Co(II) and Ni(II) did show minor
increases at 10 mM Zn(II): 1 mM Mn(II), but as accumulation of
these metal ions were not observed at other concentrations the
significance of these changes were not readily apparent. Overall,
these data indicate that the competitive effect of Zn(II) was
primarily restricted to the Mn(II) uptake pathway. Collectively,
these data provide direct quantitative evidence that extracellular
Zn(II) competitively inhibits Mn(II) uptake in S. pneumoniae in a
dose dependent manner and that the effect of Zn(II) primarily
occurs on this pathway with negligible effects on other transition
row metal ion transporter or the Zn(II) homeostatic mechanisms.
Figure 1. In vitro S. pneumoniae growth and metal ion accumulation. (A) Growth curves of S. pneumoniae grown in CDM with the following
Zn(II):Mn(II) ratios (in mM): 300:1 (orange line, open diamond), 100:1 (purple, open triangle), 30:1 (red, open square), 10:1 (blue, open inverted
triangle), and 1 mM Mn(II) (black, filled circle), respectively. Data are mean (6 SEM) absorbance measurements from three independent biological
experiments. Error bars, where not visible, are overlapped by the data points. (B and C) S. pneumoniae total cellular accumulation of Mn(II) (B) and
Zn(II) (C) determined by ICP-MS of cells grown in following Zn(II):Mn(II) ratios (in mM): 100:1 (purple), 30:1 (red), 10:1 (blue), and 1 mM Mn(II) (black).
Data are mean (6 SEM) mg metal.g dry cell mass21 from duplicate measurements of at least 3 independent biological experiments. (D) Growth curves
of S. pneumoniae grown in CDM with the following Zn(II):Mn(II) ratios (in mM): 300:300 (orange line, filled diamond), 100:100 (purple, filled triangle),
30:1 (red, filled square), 10:1 (blue, filled inverted triangle), and 1 mM Mn(II) (black, filled circle), respectively. Data are means (6 SEM) A600
measurements from three independent biological experiments. (E and F) S. pneumoniae total cellular accumulation of Mn(II) (E) and Zn(II) (F)
determined by ICP-MS of cells grown in following Zn(II):Mn(II) ratios (in mM): 300:300 (orange), 100:100 (purple), 30:30 (red), 10:10 (blue), and CDM +
1 mM Mn(II) (black). Data are mean (6 SEM) mg metal.g dry cell mass21 from duplicate measurements of at least 3 independent biological
experiments. Statistical significance of the differences in the means was determined by a two-tailed unpaired t-test (n.s. corresponds to not significant
and **** to P value , 0.0001).
doi:10.1371/journal.pone.0089427.g001
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Zinc-induced manganese starvation results in
hypersensitivity to oxidative stress.
Loss of Mn(II) uptake has previously been associated with a
reduction in the ability of S. pneumoniae to survive chemically- and
immune effector-cell mediated oxidative stress [23,26,41]. How-
ever, the molecular basis underlying this susceptibility has been
unclear. Prior studies by our group and others have reported that a
S. pneumoniae DpsaA mutant strain is hypersensitive to both H2O2
and paraquat mediated oxidative stress [23,26,41]. Paraquat
causes oxidative damage by promoting a futile redox cycle in the
cytoplasm that generates superoxide radicals. In principle, these
ROS would be detoxified by the pneumococcal superoxide
dismutase (SodA). However, it has also been reported that
supplementation of the DpsaA strain with Mn(II) failed to restore
protection from paraquat despite the mutant strain showing near
wild-type levels of SOD activity [41]. Consequently, in this work
we sought to further elucidate the connection between Mn(II) and
resistance to oxidative stress. By manipulating Zn(II) concentra-
tions in CDM it is possible to modulate the efficacy of Mn(II)
uptake by S. pneumoniae and thereby delineate the effects of Mn(II)
and SodA in pneumococcal response to ROS.
Previously we showed that during growth in 100 mM
Zn(II):1 mM Mn(II) S. pneumoniae survival, when challenged with
paraquat, was significantly reduced [26]. In this study we observed
a similar effect with a significant reduction in survival to 32%
(P=0.0252), by comparison with growth in CDM with 1 mM
Mn(II) (Fig. 3A). Here we show that upon supplementation with
an equimolar ratio of Mn(II), wild-type resistance to paraquat
exposure could be restored (Fig. 3A). Taken together these data
indicate that resistance to paraquat exposure directly correlates
with Mn(II) accumulation and was independent of the Zn(II)
concentration in the extracellular medium. These observations are
also consistent with the hypothesis that the pneumococcus utilizes
Figure 2. Competitive effect of Zn(II) on metal ion accumulation. (A) The concentration response curve fitting data for Mn(II) accumulation in
S. pneumoniae D39 under extracellular Zn(II) stress. Data were normalized by comparison with non-competitive growth conditions [CDM + 1 mM
Mn(II)]. Curve fitting was performed in Graphpad Prism version 5.0d (Graphpad). (B, C, D, and E) S. pneumoniae total cellular accumulation of Fe(II/III)
(B), Co(II) (C), Ni(II) (D), and Cu(II) (E), determined by ICP-MS, when grown in CDM supplemented with 1 mM Mn(II), 10 mM Zn(II):1 mM Mn(II), 30 mM
Zn(II):1 mM Mn(II), and 100 mM Zn:1 mM Mn. Data are mean (6 SEM) mg metal.g dry cell mass21 measurements from duplicate measurements of at
least 3 independent biological experiments. The statistical significance of the differences in concentrations was determined by a two-tailed unpaired
t-test (n.s. corresponds to not significant, * to P value , 0.05, and ** to P value , 0.01).
doi:10.1371/journal.pone.0089427.g002
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Mn(II) as a cofactor for SodA, as has previously been implicated
for S. pneumoniae and other streptococcal species [35,36,38]_EN-
REF_11. To further examine the effect of Zn(II)-induced Mn(II)
starvation, we analyzed the effect of the 100 mM Zn(II):1 mM
Mn(II) treatment on S. pneumoniae by qRT-PCR. The transcription
of sodA was significantly down-regulated by 3.8-fold (P value
= 0.0078). This occurred concomitantly with a significant increase
in psaA transcription of 11.3-fold (P value = 0.0049) (Fig. 3B). The
observed down-regulation of sodA transcription was similar to that
previously reported for the S. pneumoniae D39 DpsaA strain and this
provided further support for the inference that the down-
regulation of sodA was due to a Mn(II)-specific regulatory effect
independent of Zn(II) concentrations [31]. Collectively, these data
show that sodA transcription is regulated by Mn(II) abundance,
and it is the resulting loss of Mn(II) that leads to a reduction in sodA
transcription, which correlates with the heightened sensitivity to
oxidative stress.
Sensitivity of S. pneumoniae to oxidative killing is
primarily dependent on SodA.
We then constructed a mutant strain deficient in SodA to
ascertain whether Mn(II) was capable of directly protecting against
paraquat exposure or whether SodA was required. The mutant
strain showed almost wild-type growth (Fig. 3C) and ICP-MS
analysis confirmed that loss of the sodA gene had no effect on metal
accumulation, with the mutant strain showing wild-type accumu-
lation of Mn(II) (8066 mg Mn(II).g cells21 [n=8]) and Zn(II)
(7266 mg Zn(II).g cells21 [n=8]). However, upon treatment with
paraquat the DsodA strain demonstrated hypersensitivity to
oxidative killing with less than 1% survival (Fig. 3A). Therefore,
it can be concluded that SodA has a crucial role in protection
against paraquat mediated oxidative stress.
To further investigate whether protection against oxidative
stress during exponential growth required Mn(II) or SodA, Mn(II)-
replete exponential phase wild-type S. pneumoniae were challenged
with a concentration of Zn(II) [300 mM Zn(II):1 mM Mn(II)] that
would prevent any subsequent Mn(II) uptake, leading to depletion
of endogenous Mn(II) by cell division. Figure 3C shows that wild-
type S. pneumoniae was able to grow for approximately 180 minutes
before cell growth stopped in response to a high level of Zn(II)
stress. By contrast, when exposed to 300 mM Zn(II):1 mM Mn(II)
the DsodA strain stopped exponential growth within 60 minutes
(Fig. 3C). Therefore, although the DsodA strain is hypersensitive to
superoxide, it was the subsequent depletion of Mn(II) via
extracellular Zn(II) that resulted in a more rapid attenuation in
growth by comparison to the wild-type strain. Thus, it can be
inferred that, although Mn(II) does provide some degree of
protection against oxidative stress independently of SodA,
protection against endogenous oxidative stress appears to
predominantly arise from the action of SodA. Taken together,
these results demonstrate that Mn(II) has a crucial role in S.
pneumoniae growth where it provides protection from oxidative
stress, primarily associated with SodA, but also through a lower
efficiency secondary mechanism.
S. pneumoniae SodA is a cambialistic superoxide
dismutase that can utilize Mn(II) and/or Fe(II) cofactors,
but which is transcriptionally regulated by Mn(II).
Collectively, the above data indicate that S. pneumoniae resistance
to oxidative stress depends upon Mn(II) accumulation to permit
sodA transcription. In 2000 Yesilkaya and coworkers concluded
that SodA contained a Mn(II)-cofactor on the basis of its
susceptibility to chemical inhibitors [35]. However, we sought to
obtain further insight into SodA by cloning and recombinantly
expressing the S. pneumoniae sodA gene (rSodA). Purified rSodA,
which had a molecular mass of ,27.5 kDa under denaturing
conditions (Fig. 4A), showed a native molecular mass of 60.8 kDa
on gel permeation chromatography (Fig. 4B), consistent with the
theoretical mass of a homodimer (,55 kDa). Intriguingly, ICP-
MS analysis revealed that the as-purified protein contained
0.1760.0 mol Mn(II).mol monomer21 and 0.7260.0 mol Fe(II).-
mol monomer21. As the acquisition of the metal cofactor by
rSodA may have been influenced by the recombinant protein
expression and culture medium used, the purified protein was
subjected to denaturing chelation treatment and then reconstituted
with either Mn(II) or Fe(II). The reconstituted isoforms of rSodA
had metal:protein stoichiometries of 0.760.05 mol Mn(II).mol
monomer21 for the Mn(II) reconstituted protein and
1.060.04 mol Fe(II).mol monomer21 for the Fe(II) reconstituted
protein. Activity assays (Fig. 4C) showed that rSodA had the
highest activity when loaded with Mn(II) (0.6060.01 U. mM21
rSodAMn), but was active, albeit to a lesser extent, when loaded
with Fe (0.4060.01 U. mM21 rSodAFe). The apo-protein was
essentially inactive (0.0160.00 U. mM21 rSodA) consistent with
the requirement of a metal cofactor for function. Taken together,
these data indicate that S. pneumoniae SodA is most likely a
cambialistic enzyme capable of utilizing Mn(II) or Fe(II) cofactors
similar to SodA from other streptococcal species [38].
The cambialistic capacity of rSodA, similar to that reported for
other streptococcal species [38], raised the possibility that its
transcription may also be responsive to Fe(II). However, this
seemed unlikely as an analysis of the upstream region of the sodA
gene failed to reveal any known iron-transcriptional regulator sites.
The effect of Fe(II) concentrations was assessed by examining the
effect of S. pneumoniae grown in CDM supplemented with 1 mM
Mn(II), high-Fe(II) [CDM supplemented with 100 mM
Fe(II):1 mM Mn(II)], and low-Fe(II) [CDM with 1 mM Mn(II)
treated with the specific Fe-chelating agent 2,29-dipyridyl].
Analysis of cells grown in the presence of high-Fe(II) showed
minor, but significant, increases in both Mn(II) (133616 mg
Mn(II).g cells21 [n=4]) and Zn(II) (148611 mg Zn(II).g cells21
[n=6]) accumulation. Consequently, an excess of Fe(II) did not
appear to negatively affect acquisition of other transition row
metal ions. Analysis of whole cell extracts revealed that alterations
in CDM Fe(II) concentrations did not affect superoxide dismutase
activity despite increased sensitivity to oxidative stress seen under
high-Fe(II) (Fig. 5A,B). Whereas the 100 mM Zn(II):1 mM Mn(II)
treatment resulted in down-regulation of sodA, qRT-PCR analysis
of gene expression of psaA and sodA between S. pneumoniae grown in
high- or low-Fe relative to CDM + 1 mM Mn(II) suggested that if
Fe(II) does regulate sodA transcription, it is subordinate to Mn(II)
(Fig. 5C,D). Collectively, these data indicate that Mn(II)
transcriptionally regulates sodA as modulation of Fe(II) concen-
trations in the media had no direct effect on its expression, despite
the cambialistic nature of enzyme.
Discussion
Recently we established that high concentrations of extracellular
Zn(II) were associated with reduced Mn(II) accumulation by the
pneumococcus due to impairment of the high-affinity Mn(II)
permease, PsaBCA [26,40]. In this study we have now provided
quantitative data that directly shows that Zn(II) acts as a
competitive inhibitor of Mn(II) uptake, supporting our earlier
inference, and directly demonstrating that this occurs in a dose
dependent manner. Analysis of other transition row metal ions
revealed that the impact of Zn(II) on S. pneumoniae was restricted to
Zn(II) Competes for Mn(II) Uptake in S. pneumoniae
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Mn(II). This would be consistent with the pneumococcus only
employing cluster A-I SBPs for the purpose of Zn(II)- or Mn(II)-
recruitment. Intriguingly S. pneumoniae grown in 10 mM
Zn(II):1 mM Mn(II) showed a minor but significant increase in
Co(II) and Ni(II) accumulation. However, as an increase in the
accumulation of these metals was not observed at any other
competitive Zn(II) concentration the data does not indicate that
this effect is directly related to increases in extracellular Zn(II).
Cu(II) accumulation also fluctuated, but as the differences in
concentrations never achieved significance, the data suggest that
Cu(II) accumulation is less sensitive than Mn(II) to perturbation by
extracellular Zn(II). Further support for the competitive model of
Zn(II) inhibition of Mn(II) uptake can be derived from the
observations that the phenotypic impact of extracellular Zn(II) on
growth was abrogated, at almost all concentrations, by supple-
mentation with Mn(II) and that cell-associated Mn(II) was
similarly restored to unchallenged levels. This supports the
inference that it is not the concentration of Zn(II) that is directly
harmful to the pneumococcus but, instead, the ratio of Zn(II) to
Mn(II) that results in the competitive inhibition of the Mn(II) ABC
permease. Our data, and that interpretation, are also entirely
consistent with the ,70-fold greater affinity of PsaA for Mn(II)
over Zn(II), which would predict that, in the presence of equimolar
Mn(II) and Zn(II), PsaA would preferentially interact with Mn(II)
Figure 3. S. pneumoniae response to oxidative stress. (A) Paraquat killing of the S. pneumoniae wild-type (D39) and DsodA mutant grown in
CDM + 1 mMMn(II) (white), and S. pneumoniae (D39) grown in 100 mM Zn(II):100 mM Mn(II) (black) or 100 mM Zn(II):1 mM Mn(II) (light gray) conditions.
Survival was calculated as a percentage of c.f.u. after 30 minutes paraquat challenge compared to 30 minutes without challenge. The experiment was
performed with 3 independent biological samples and data are the means (6 SEM). The statistical significance of the differences in mean survival was
determined by a two-tailed unpaired t-test (n.s. corresponds to not significant, * corresponds to P value , 0.05, and **** P value , 0.0001). (B) S.
pneumoniae D39 mRNA transcription levels were examined after growth in CDM + 1 mMMn(II) or 100 mM Zn(II):1 mMMn(II). Real-time RT-PCR data for
the indicated conditions were normalized against those obtained for the 16S rRNA control. Data are means (6 SEM) of at least three biological
replicates. The statistical significance of the differences in relative transcription level was determined by a two-tailed unpaired t-test (* corresponds to
P value , 0.05, and ** to P value , 0.01). (C) S. pneumoniae D39 (filled) and DsodA (open) were grown in CDM supplemented with 1 mM Mn(II) until
an A600 of 0.3 was reached. Cells were washed in CDM and then inoculated to an A600 of 0.05 in CDM consisting of in CDM + 1 mM Mn(II) (circle) or
300 mM Zn(II):1 mM Mn(II) (square). Data are means (6 SEM) A600 measurements from three independent biological experiments. Error bars, where
not visible, are overlapped by the data points.
doi:10.1371/journal.pone.0089427.g003
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[26]. However, this study also highlights the fact that the in vitro
affinity constants do not reflect the cell-surface environment of the
pneumococcus, as the observed EC50 for Zn(II) inhibition of
Mn(II) uptake is greater than would be otherwise expected.
Whether this arises from considerations of the Irving-Williams
series with respect to protein-metal ion interaction [42,43], the
prevailing metal ion availability, or due to complexities of the
protein and polysaccharide composition of the cell wall and
membrane, requires further investigation.
This work also revealed an apparent limitation of PsaA. In
almost all cases, extracellular Zn(II) had negligible effect on cell
associated Zn(II). However, growth in 100 mM Zn(II):1 mMMn(II)
ratio led to a higher association of Zn(II) with total cellular
material than might otherwise be expected if Zn(II) were not being
specifically accumulated in the cytoplasm. Although the possibility
that Zn(II) could be imported through PsaBCA cannot be
completely excluded, recent in vitro characterization of PsaA
showed that Zn(II)-binding to the protein was essentially
irreversible [40]. Furthermore, this inference is also supported
by a similar observation reported for the PsaA homolog, MntC,
from Staphylococcus aureus [44]. Thus, we speculate that, concom-
itant with the up-regulation of psaA transcription due to Mn(II)
depletion, the increase in Zn(II) at the cell-surface during growth
in 100 mM Zn(II):1 mM Mn(II) arises from Zn(II) competing with
Mn(II) and irreversibly binding to PsaA leading to Zn(II)-PsaA
accumulating at the cell-surface.
At higher ratios of Zn(II), 300 mM Zn(II):300 mM Mn(II), even
though growth could be restored, by contrast with the complete
inhibition of growth at 300 mM Zn(II):1 mM Mn(II), it was not
restored to unchallenged wild-type levels. This observation
correlated with the increased association of Zn(II) with cellular
material, even though the Mn(II) accumulation was restored to
unchallenged levels. This could be explained by the higher ratio of
extracellular Zn(II) to other cations facilitating its accumulation at
the cell surface or leading to it being transported into the cell via
pathway(s) independent of PsaA. Collectively, our data support a
model whereby extracellular Zn(II) primarily competes for the
SBP of the Mn(II) ABC permease. However, this work also shows
that at very high ratios of Zn(II), independent of Mn(II) uptake,
other transport processes are also susceptible to Zn(II) competition
leading to deleterious cellular consequences, such as impaired
biogenesis of iron sulfur cluster containing enzymes [45].
These observations are also significant in terms of host-
pathogen interplay. In recent years, the ability of the host to
exploit the essential nature of transition metals by restricting their
availability has become increasingly understood and is now
referred to as ‘‘nutritional immunity’’ [46,47]. Although host
restriction of iron has been studied for many decades [48–50],
more recent work has identified that the bioavailability of Mn(II)
and Zn(II) can also be modulated by the host organism during
infection [26,51,52]. The host factors that facilitate these processes
are still under investigation, but recent studies of the Gram-
positive human pathogen Staphylococcus aureus have elegantly
revealed that the host S100 protein calprotectin has a major role
in cation sequestration and impedes staphylococcal infection
[51,53]. Our earlier finding, that Zn(II) abundance increased
during pneumococcal infection, suggested that Zn(II) may also act
as a component of nutritional immunity [26]. This supposition
would correlate with the observations that the pneumococcal
Mn(II) ABC permease is essential for infection [23], that
pneumococcal burden increases in Zn(II)-deficient animal models
[54,55], and that dietary Zn(II) deficiency is one of the major
factors associated with the incidence and severity of pneumococcal
infections in children [56,57]. Thus, the observations in this work
offer a potential mechanism by which Zn(II) could act in
nutritional immunity. Inhibition of the pneumococcal Mn(II)
ABC permease occurred by a competitive mechanism wherein, as
the ratio of Zn(II) relative to Mn(II) increased, the capacity of the
ABC permease to import Mn(II) was decreased. Pneumococcal
infection has previously been shown to result in an increase in
Zn(II) relative to Mn(II) in the niches colonized by the pathogen,
i.e. brain, lung, nasopharynx, and blood serum [26]. The
Zn(II):Mn(II) ratios in all niches studied in that work would all
exceed the EC50 [30 Zn(II):1 Mn(II)] observed for inhibition of
Mn(II) uptake determined here. Taken together, these findings
would be consistent with Zn(II) abundance serving to ablate
Mn(II) uptake by a competitive mechanism. However, we would
stress that we do not yet have direct evidence that Zn(II) is acting
to inhibit pneumococcal colonization, as Zn(II) has many roles in
immune function, and that further studies are required.
Figure 4. rSodA purification and characterization. (A) Purified rSodA electrophoretically separated on a 12.5% SDS polyacrylamide gel, with
the major band stained by PAGE Blue. (B) Determination of the apparent molecular mass of the purified rSodA by gel-permeation chromatography
on a Superdex 200 10/300 column. Inset is the linear regression of the protein molecular mass standards used to calibrate the column (carbonic
anhydrase = 29 kDa, bovine serum albumin = 66 kDa, yeast alcohol dehydrogenase = 150 kDa, sweet potato b-Amylase = 200kDa). rSodA eluted
with a calculated molecular mass of 60.8 kDa. (C) The SOD activity of apo-rSodA (white) and rSodA loaded with Mn(II) (black) or Fe(II) (light gray) was
measured. The data are presented as SOD activity units (U) per mM protein. Data are means (6 SEM) of three biological replicates.
doi:10.1371/journal.pone.0089427.g004
Zn(II) Competes for Mn(II) Uptake in S. pneumoniae
PLOS ONE | www.plosone.org 7 February 2014 | Volume 9 | Issue 2 | e89427
The heightened sensitivity of the pneumococcus to chemically
induced oxidative stress when starved of Mn(II), is consistent with
our prior observations and those in other streptococcal species
[26,36–38]. Here, we have directly shown the relationship
between Mn(II) and SodA. It should be noted that S. pneumoniae
was originally reported to contain two SODs, with SodA
demonstrated to be the major SOD at a functional level and a
weakly expressed secondary pneumococcal SOD suggested to be a
Fe-SOD [35]. However, the identity of this secondary SOD
remains unclear, as no other SOD-like genes are present in the S.
pneumoniae genome and no similar reports of a second Fe-SOD
have been reported in other streptococcal species. In this study we
have focused exclusively on SodA, and the increased sensitivity to
O2
2 ions associated with Mn(II) starvation can be directly
attributed to decreased sodA transcription. Despite our observa-
tions of manganese responsive regulation of sodA, PsaR, the
regulator of the psa permease, did not regulate the gene. No
consensus PsaR binding sites were identified in the vicinity of the
sodA gene, consistent with recent studies of psaR deletion strains
[58]. Furthermore, no regulatory motifs corresponding to other
Figure 5. The effect of metal ions on SodA protection during oxidative stress. (A) Intracellular SOD activity of S. pneumoniae D39 grown in
CDM supplemented with 1 mM Mn(II) (white), 100 mM Zn(II):1 mM Mn(II) (black), 100 mM Zn(II):100 mM Mn(II) (light gray), 100 mM Fe(II):1 mM Mn(II)
(dark gray), 1 mMMn(II) + 100 mM 2,2’-dipyridyl was measured (white striped). The S. pneumoniae DsodA mutant strain [1 mMMn(II)] was included as a
negative control. The activity units were corrected for total protein and normalized to S. pneumoniae D39 grown in CDM + 1 mM Mn(II). Data are
means (6 SEM) of duplicate reactions from three biological replicates. (B) Paraquat killing of S. pneumoniae D39 grown in CDM + 1 mM Mn(II) (white)
or 100 mM Fe(II):1 mM Mn(II) (black) was assessed. Survival was calculated as a percentage of c.f.u. after 30 minutes paraquat challenge compared to
30 minutes without challenge. The experiment was performed with at least 3 independent biological samples and data are the means (6 SEM). (C
and D) S. pneumoniae D39 mRNA transcription levels of (C) psaA and (D) sodA were examined after growth in CDM + 1 mM Mn(II) (white), 100 mM
Fe(II):1 mM Mn(II) (black) or 1 mM Mn(II) + 100 mM 2,29-dipyridyl (light gray). Real-time RT-PCR data for the indicated conditions were normalized
against those obtained for the 16S rRNA control. Data are means (6 SEM) of at least three biological replicates. The statistical significance of the
differences in observed means was determined by a two-tailed unpaired t-test (n.s. corresponds to not significant, * corresponds to P value, 0.05, **
to P value , 0.01, *** to P value , 0.001, **** to P value , 0.0001).
doi:10.1371/journal.pone.0089427.g005
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known regulatory proteins could be found in the upstream region
of the sodA gene. Taken together, the absence of PsaR binding sites
and the lack of a direct response of sodA to the other divalent
cations, i.e. Zn(II) or Fe(II) supplementation in the media, suggests
that an unknown Mn(II)-responsive regulator principally regulates
sodA. Despite this, the in vivo physiological cofactor of SodA from
the pneumococcus remains unclear. Recombinant SodA was
found to have cambialistic SOD capability as evidenced by its
ability to function with either Fe(II) or Mn(II) cofactors. If this does
reflect the in vivo scenario, this may be beneficial for S. pneumoniae as
cambialistic SODs have been shown to be more resistant to H2O2
inactivation than Fe-SODs [38]. However, we have no direct
evidence that the observed in vitro cambialistic capacity of
recombinant SodA also occurs in S. pneumoniae under physiological
conditions. Despite this, recent studies from other streptococci
have suggested that cambialistic SODs may be more common
than anticipated and are not easily deduced from amino acid
sequence analyses [36,38].
An additional benefit of a cambialistic SOD for S. pneumoniae
could arise from the lack of a known iron efflux pathway in the
pneumococcus. As a consequence, SodA may also serve a role in
Fe-homeostasis with Mn(II) and Fe(II) being able to exchange on
the protein. Further investigation into the interplay between Fe(II)
and Mn(II) homeostasis will be required to elucidate these aspects
of SodA function. However, it cannot be discounted that there
could be a cost associated with variations in ratio of Fe(II) and
Mn(II) in the SodA metal-cofactor. Our observations showed that
the activity of SodA varied depending on the metal cofactor. In a
physiological context, changes in the metal ratios of SodA could
result in alterations in the resistance profile of S. pneumoniae to
oxidative stress, independent of variations arising from changes in
sodA transcriptional levels. This model offers a potential explana-
tion for the minor, but significant, reduction in S. pneumoniae cell
survival that was observed for cells grown in the presence of high
iron (Fig. 5B), as the Fe(II)-cofactor SodA showed a lower level of
in vitro activity by comparison with the Mn(II)-cofactor containing
isoform (Fig. 4C). Furthermore, the potential for modulation of the
metal cofactor of SodA by virtue of metal abundance could have
ramifications for growth in the presence of high extracellular
Zn(II). Although Zn(II) did not appear to be directly responsible
for the observed sensitivity to oxidative stress, as the sensitive
phenotypes could be reversed by supplementation with Mn(II), we
cannot exclude the possibility that Zn(II) could also be contrib-
uting to the phenotype. Despite the lack of direct redox activity,
Zn(II) could, via mismetallation and inactivation of proteins such
as SodA, perturb the intracellular redox balance of S. pneumoniae
independent of any impact on Mn(II) uptake. However, although
the potential contribution of Zn(II)-mismetallation cannot be
discounted, overall our data supports the less speculative
conclusion that the principal effect of extracellular Zn(II)
competition is Mn(II) starvation, which results in decreased sodA
transcription and a concomitant increase in sensitivity to oxidative
stress.
Analysis of the DsodA strain confirmed that despite being replete
for Mn(II), it was hypersensitive to chemically induced oxidative
stress. However, the Mn(II) ion was able to provide near wild-type
levels of protection from endogenous oxidative stress as abrogating
Mn(II) uptake and allowing it to be depleted by cell-division led to a
rapid attenuation of growth of the DsodA strain relative to the wild-
type strain. Taken together these data indicate that the Mn(II) ion
can directly protect against oxidative stress. Several models for how
Mn(II) can directly provide protection against oxidative stress have
recently been proposed, but the precise nature of this secondary
mechanism in S. pneumoniae remains unclear. Irrespective of the
mechanism, it is clear that SodA is much more efficient in providing
protection against oxidative stress.
In conclusion, this study shows that extracellular Zn(II) depletes
Mn(II) accumulation in S. pneumoniae via competitive inhibition of
the PsaBCA permease. The Zn(II)-induced Mn(II)-starvation
results in a loss of SodA and Mn(II) and thereby leads to a
hypersensitivity towards oxidative stress. Collectively these findings
are significant in the context of host nutritional immunity, as the
ratios of Zn(II) to Mn(II) in those niches colonized by the
pneumococcus [26] have previously been reported to be greater
than the EC50 reported here. Thus, this work offers a potential
mechanism by which Zn(II) could act as a component of
nutritional immunity.
Materials and Methods
In vitro growth measurements
Frozen stock S. pneumoniae D39 and mutant isoforms were
prepared as described previously [26]. The medium used for in
vitro growth measurements was cation-defined C+Y medium
(CDM) as specified previously [26,59]. ICP-MS of CDM was
routinely performed to determine metal ion concentrations of the
unsupplemented media. For in vitro growth experiments, culture
was added to CDM supplemented with 1 mM MnSO4 and then
supplemented with additional MnSO4 and/or ZnSO4 to the
provide the ratios of metal ions as specified. The presence of other
transition row metal ion concentrations in the CDM, as indicated
by ICP-MS, were 4–5 mM Fe(II/III), 100–200 nM Co(II), 100–
200 nM Ni(II), 100–200 nM Cu(II). The starting A600 was 0.05 for
all cultures. For the extracellular Zn(II) stress experiment a stock
culture was added to CDM with 1 mM MnSO4 to a starting
absorbance at 600 nm (A600) of 0.05 and grown to an A600 of 0.5.
Cells were washed with CDM, pre-warmed to 37uC, and then
reinoculated into CDM with 1 mM MnSO4 and supplemented
with either 0 or 300 mM ZnSO4, to an A600 of 0.3. Cell growth
was then monitored at A600. All analyses were carried out in at
least biological triplicate. For ICP-MS analyses, cells were grown
in 50 mL of CDM supplemented with metals as indicated. Cell
growth was monitored to an A600 of 0.3 after which the cells were
harvested by centrifugation at 3,750 x g for 15 minutes at 8uC and
washed 3 times, at 3,750 x g for 15 minutes at 8uC, in PBS +
5 mM EDTA and then washed 3 times with PBS at 3,750 x g for
15 minutes at 8uC. The concentration of the chelating agent used
had been verified to be in a sufficiently large molar excess (. 500-
fold) relative to media metal ion concentrations to remove metal
ions associated with the cell surface of S. pneumoniae. Cells were
transferred to pre-weighed tubes and heated at 80uC overnight.
The dry cell mass was determined and the material boiled at 95uC
for 20 minutes in 35% HNO3. The metal-ion containing
supernatant was collected by centrifugation at 14,000 x g for 30
minutes and diluted to a final concentration of 3.5% HNO3 for
metal ion composition determination on an Agilent 7500cx ICP-
MS (Adelaide Microscopy, University of Adelaide).
Construction of the S. pneumoniae DsodA strain
Primers were designed to replace the sodA genes with a
spectinomycin acetyltransferase gene, by overlap extension PCR
[60]. Then, the sodA overhanging fragment was transformed into
S. pneumoniae [59,61]. The DsodA mutant was confirmed by DNA
sequencing (Australian Equine Genetics Research Centre, The
University of Queensland). Primer sequences are presented in
Table S1.
Zn(II) Competes for Mn(II) Uptake in S. pneumoniae
PLOS ONE | www.plosone.org 9 February 2014 | Volume 9 | Issue 2 | e89427
Expression and purification of rSodA
Recombinant SodA was generated by PCR amplification of S.
pneumoniae D39 sodA, using primers listed in Table S1, and ligation
independent cloning was used to insert the gene into a C-terminal
dodecahistidine tag containing vector, pCAMcLIC01, to generate
pCAMcLIC01-SodA. High level protein expression was per-
formed in E. coli LEMO21(DE3) grown in an autoinducing TB
medium (Overnight Express, Merck) for 18 hours at 30uC. Cells
were harvested and disrupted at 30 kPSI by a Constant Systems
cell disruptor and the soluble supernatant isolated by centrifuga-
tion at 4uC for 60 minutes at 120,000 x g. rSodA was isolated in a
HisTrap HP column on an AKTA Purifier and was further
purified on a Superdex 200 10/300 gel permeation column.
Apo-rSodA generation, refolding, and ICP-MS
Demetallated (apo) rSodA was prepared by dialyzing the
protein (10 ml) in a 20kDa MWCO membrane (Pierce) against
4 L of sodium acetate buffer, pH 3.7, with 20 mM EDTA. The
sample was then dialyzed against 4 L of 20 mM Tris-HCl,
pH 7.2, 100 mM NaCl, at 4uC. The sample was then recovered
and centrifuged at 18,000 x g for 10 minutes to remove any
insoluble material. The sample was analyzed for metal content by
boiling 10 mM protein at 95uC for 30 minutes in 3.5% HNO3.
Samples were analyzed on an Agilent 7500cx ICP-MS (Adelaide
Microscopy, University of Adelaide). Apo-rSodA was reconstituted
in the presence of 10-fold excess of MnSO4 or FeCl2 for 30
minutes on ice. The protein was desalted on a PD10 column (GE
Healthcare) and then used in SOD assays (Sigma-Aldrich).
Real-time RT-PCR
S. pneumoniae D39 for transcription analyses were cultured as
described above. Cells were harvested by centrifugation at 3,750 x
g for 15 minutes at 8uC and subsequently lysed using TRIzol
(Invitrogen) and chloroform. Following phase separation by
centrifugation, RNA was purified using an RNA isolation kit
(Ambion) and treated with DNase I (NEB). The RNA was reverse
transcribed using random hexamers and qPCR was performed
using a Roche LC480 Real-Time Cycler, as described previously
[59]. The primers are listed in Table S1 and were used at a final
concentration of 200 nM per reaction. 16S rRNA was employed
as a control. Amplification data were analyzed using the
comparative critical threshold (22nnCT) method.
Bacterial killing assays
Bacteria were grown to an A600 = 0.3 in minimal media with or
without Zn(II) supplementation, washed 3 times with PBS +
2.5 mM EDTA to remove excess cations and then 3 times with
PBS. Cells were incubated for 30 minutes with 60 mM paraquat
(Sigma-Aldrich) and then serially diluted and plated on blood-
agar. Plates were incubated overnight at 37uC + 5% CO2. Survival
was calculated as the percentage of colony forming units (c.f.u.)
after 30 minutes of paraquat challenged compared to the number
of c.f.u. after 30 minutes without paraquat challenge [26].
Supporting Information
Table S1 Oligonucleotide primers used in this study.
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